Clinical Trial

Safety and Effectiveness of GENOSS® DES in Patients With Multivessel Coronary Artery Disease

Study acronym: GENOSS-MV
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The investigators intend to establish a multicenter prospective observational study by enrolling and tracking patients with multivessel coronary artery disease (MVCAD) using Genoss DES, a device manufactured with pure domestic technology. The study aims to evaluate the efficacy and safety of Genoss DES in MVCAD patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-12-05.
Status change: Recruiting → Enrolling by Invitation 2025-09-30
Trial Details
NCT Number NCT06168305
Lead Sponsor Genoss Co., Ltd.
Conditions Percutaneous Coronary Intervention, Multivessel Coronary Artery Disease
Enrollment 1,000 participants
Start Date 2023-11-15
Primary Completion 2028-02-28 (estimated)
Study Completion 2028-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-10-06